Data Year:

For its 2025 fiscal year, HCA HEALTHCARE INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In Healthcare industry
Samuel N. Hazen
Chief Executive Officer
Total Compensation $24,522,206 View details Pay Rank By Title In Healthcare industry #3 View more
Jon M. Foster
Executive Vice President and Chief Operating Officer
Total Compensation $7,570,757 View details Pay Rank By Title In Healthcare industry #5 View more
Michael S. Cuffe M.D.
Executive Vice President and Chief Clinical Officer
Total Compensation $5,704,197 View details Pay Rank By Title In Healthcare industry #3 View more
Michael R. McAlevey
Executive Vice President - Chief Legal and Administrative Officer
Total Compensation $5,710,335 View details Pay Rank By Title In Healthcare industry #2 View more
Michael A. Marks
Executive Vice President and Chief Financial Officer
Total Compensation $7,049,729 View details Pay Rank By Title In Healthcare industry #5 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at HCA HEALTHCARE INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. HCA HEALTHCARE INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. HCA HEALTHCARE INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Samuel N. Hazen
Chief Executive Officer
Total Cash $6,994,547 Equity $16,988,633 Other $539,026 $24,522,206
Jon M. Foster
Executive Vice President and Chief Operating Officer
Total Cash $3,601,924 Equity $3,815,021 Other $153,812 $7,570,757
Michael S. Cuffe M.D.
Executive Vice President and Chief Clinical Officer
Total Cash $2,893,440 Equity $2,543,385 Other $267,372 $5,704,197
Michael R. McAlevey
Executive Vice President - Chief Legal and Administrative Officer
Total Cash $2,999,326 Equity $2,543,385 Other $167,624 $5,710,335
Michael A. Marks
Executive Vice President and Chief Financial Officer
Total Cash $3,405,229 Equity $3,560,694 Other $83,806 $7,049,729
For its 2025 fiscal year, HCA HEALTHCARE INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Samuel N. Hazen CEO Pay $26,456,606 Median Employee Pay $62,955 CEO Pay Ratio 420:1
For its 2025 fiscal year, HCA HEALTHCARE INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Andrea B. Smith Total Cash $371,515
Hugh F. Johnston Total Cash $417,347
John W. Chidsey, III Total Cash $230,926
Meg G. Crofton Total Cash $41,071
Michael W. Michelson Total Cash $432,399
Nancy-Ann DeParle Total Cash $371,515
Robert J. Dennis Total Cash $363,652
Thomas F. Frist, III Total Cash $449,566
Wayne J. Riley, M.D. Total Cash $376,254
William R. Frist Total Cash $352,594
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.